EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) 21. September 2017, section EUDA news
17. December 2025 Shedding light on drug-related hospital emergencies in Europe Every year, thousands of people across Europe require hospital treatment for drug-related poisoning and other acute harms. In...
